Medical Devices

A Gold Stevie Award for hear.com isn't just a trophy; it's a market signal for how tele-audiology and AI are building a durable future for hearing care.

Advita Ortho's new Vitamin E-infused shoulder implant aims for unprecedented longevity. But is superior material science enough to disrupt the $56B market?

A struggling medical AI firm plans a merger with a crypto miner. Is this a desperate act or a brilliant new model for funding deep tech innovation in 2026?

A new solution from Alps Dx targets the messy, error-prone start of oral fluid testing, signaling a major shift toward automated, reliable diagnostics.

A new pilot by Teal Health and UC Davis Health integrates an FDA-authorized self-collection kit into hospital workflows, targeting overdue patients.

With a mixed Q1 and a promise of a stronger second half, Myriad Genetics' upcoming earnings call will be a crucial test of its strategic health and pipeline.

Robotic surgery pioneer Intuitive unveils a bold AI strategy. But as rivals close in, can its vision for 'supervised autonomy' secure its market dominance?

Precision Neuroscience just gained a massive edge by bringing BCI legend John Donoghue on board. Can their 'Goldilocks' approach beat rivals to market?

A new heart valve from Venus Medtech can be fully deployed and retrieved, giving surgeons an 'undo' button that could revolutionize patient safety.

Dexcom's selection for the FDA's TEMPO pilot program pioneers a new path for AI-driven, preventative healthcare, shaking up the digital health market.

Spryte Medical's novel nOCT system offers microscopic views inside brain vessels. With its pivotal clinical trial enrollment complete, it's a step closer to FDA approval.

With fresh capital and key regulatory approvals, Median Technologies is launching its AI lung cancer tool, powered by a stable and record-setting iCRO business.

Science Corp.'s PRIMA device is a medical miracle, restoring sight to those with AMD. But can this BCI breakthrough navigate Europe's complex market hurdles?

IV complications cost the NHS millions. Now, an innovative monitoring system is being fast-tracked to prevent harm, save money, and improve patient care.

As a deadly Ebola outbreak grips Central Africa, OraSure's new 30-minute test offers a critical lifeline, empowering frontline workers without labs or power.

Aetna's new coverage for at-home vitiligo treatment marks a major win for patients and signals a broader payer shift toward accessible, tech-enabled care.

After a major restructure, Mauna Kea Technologies posts 44% growth, fueled by its Cellvizio imaging platform and a clever cash-pay model for global expansion.

Houston-based TYBR Health lands $30M to scale its B3 GEL System, a novel hydrogel aiming to shift orthopedic surgery from mere repair to managed recovery.

A new FDA-cleared VR therapy for 'lazy eye' is teaming up with Spin Master, turning screen time with shows like PAW Patrol into a medical breakthrough.

Hilo launches its wearable blood pressure system in the U.S., trading the old cuff for continuous data. Is this the future of heart health or a pricey wellness gadget?